ARK Investment Management 13F, Q4 2023

Cathie Wood · quarter ending 31 December 2023 · filed 17 January 2024 · SEC CIK 1697748

$16.89B
Filed US book
222
Positions
8.8%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q4 2023

The 25 largest of 222 positions. Weights are against the whole filed book. Changes are in shares held, against the Q3 2023 filing.

CompanyTickerValue% of bookvs Q3 2023
Coinbase Global IncCOIN$1.50B8.8%-19% shares
UiPath IncPATH$1.08B6.4%-8% shares
Tesla IncTSLA$944.85M5.6%-7% shares
Block IncXYZ$919.51M5.4%+9% shares
Roku IncROKU$873.42M5.2%-9% shares
Zoom Video Communications IncZM$788.46M4.7%+8% shares
ROBLOX CorpRBLX$544.35M3.2%unchanged
Twilio IncTWLO$540.97M3.2%unchanged
CRISPR Therapeutics AG$534.36M3.2%+19% shares
Unity Software IncU$498.44M3.0%+6% shares
Shopify IncSHOP$468.22M2.8%-14% shares
Teladoc Health IncTDOC$457.39M2.7%+5% shares
Exact Sciences CorpEXK$446.31M2.6%-4% shares
Robinhood Markets IncHOOD$445.09M2.6%+6% shares
DraftKings IncDKNG$434.18M2.6%-16% shares
Intellia Therapeutics IncNTLA$347.97M2.1%+15% shares
Pacific Biosciences of CaliforPACB$338.49M2.0%+16% shares
Ginkgo Bioworks Holdings Inc$335.65M2.0%+9% shares
Twist Bioscience CorpTWST$265.88M1.6%+6% shares
PagerDuty IncPD$264.22M1.6%+8% shares
Beam Therapeutics IncBEAM$255.70M1.5%+7% shares
10X Genomics IncTXG$226.15M1.3%+35% shares
Veracyte IncVCYT$210.61M1.3%unchanged
Recursion Pharmaceuticals IncRXRX$203.65M1.2%+200% shares
Palantir Technologies IncPLTR$187.80M1.1%+16% shares

What changed since Q3 2023

Against the Q3 2023 filing, ARK Investment Management opened 2 new positions, added to 91, trimmed 106, left 23 unchanged and exited 5. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

  • BITO$93.21M
  • ARK 21Shares Active Bitcoin Fu$836.8K

Exited

  • GBTCwas $108.05M
  • GMwas $9.66M
  • APOwas $2.49M
  • SatixFy Communications Ltdwas $5.1K
  • SPYwas $376.00

Added to

  • XYZ+9%$919.51M
  • ZM+8%$788.46M
  • CRISPR Therapeutics AG+19%$534.36M
  • U+6%$498.44M
  • TDOC+5%$457.39M
  • HOOD+6%$445.09M
  • NTLA+15%$347.97M
  • PACB+16%$338.49M

and 83 more

Trimmed

and 98 more

Other quarters

Source: SEC Form 13F-HR, accession 0001104659-24-004517, filed by ARK Investment Management LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.